Insurance and Webinar - Pharmacy Technician Pulse

Flu Vaccines Are a Go

Pharmacy Times

JULY 16, 2025

Importantly, ACIP’s recommendations do have a strong influence, if not a mandate, on health insurance companies with respect to coverage and co-payments for immunizations as well as the Vaccines for Children Program, which provides coverage for access to vaccines for those who are 18 years or younger.

Vaccines

Vaccines Community Pharmacies Immunization Compounding Pharmacies

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Insurance Coverage

Basics on Creating a Lead Generation Network in Pharma

Pharma Marketing Network

APRIL 27, 2025

Capturing contact data through gated content, webinars, or opt-in emails enables ongoing engagement and clinical education. Lead Types in Pharma In pharmaceutical marketing, leads can be categorized into HCPs looking for treatment data, patients exploring therapy options, or even insurers needing health economic outcomes.

Health and Personal Care Stores

Health and Personal Care Stores HIPAA FDA Insurance

UK enacts law to decentralise manufacture of personalised treatments

Pharmaceutical Technology

JULY 23, 2025

Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Packaging Insurance

GSK’s world-first gonorrhoea vaccine launched in England

Pharmaceutical Technology

AUGUST 5, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News GSK’s world-first gonorrhoea vaccine launched in England The immunisation programme aims to reduce rising gonorrhoea rates and address antibiotic-resistant strains. Give your business an edge with our leading industry insights.

Vaccines

Vaccines Communication Hospitals Packaging

Hengrui Pharma and GSK link across key therapeutic areas

Pharmaceutical Technology

JULY 28, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

How Has Display Advertising Changed in Pharma Marketing?

Pharma Marketing Network

AUGUST 6, 2025

Today, display campaigns can be personalized based on geography, prescription behavior, specialty, and even insurance coverage. They must act as connectors—inviting users to download white papers, sign up for webinars, or schedule rep visits. Pharma marketers no longer guess who’s seeing their messages.

Insurance Coverage

Insurance Coverage HIPAA FDA Insurance

MetrioPharm gains orphan drug status from EMA for MP1032

Pharmaceutical Technology

JULY 30, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Immunization FDA

FDA gives Arvinas and Pfizer’s vepdegestrant NDA for breast cancer

Pharmaceutical Technology

AUGUST 11, 2025

Give your business an edge with our leading industry insights.

FDA

FDA Packaging Communication Hospitals

HS market forecast to reach $7.8bn across 7MM by 2034

Pharmaceutical Technology

JULY 28, 2025

CAGR is largely attributed to the launch of novel biologics and small molecules. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Compounding

Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.

Pharmacy Times

AUGUST 1, 2025

PBMs are more powerful and influential than ever as they become extensions of major health insurers, acquire independent pharmacies, and create new business lines to funnel prescriptions through. Today, the 3 largest PBMs control 80% of the prescription drug market, smothering the competition that is needed to keep oversteps in check.

Specialty Pharmacies

Specialty Pharmacies Independent Pharmacies Mail-Order Pharmacies Compounding Pharmacies

Alfasigma sets stage for Jyseleca in axSpA after Phase III win

Pharmaceutical Technology

JULY 29, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

JULY 22, 2025

These third-party administrators act as intermediaries between drug manufacturers, pharmacies, and insurance companies. Mail-order pharmacies can offer cost savings depending on insurance coverage and are well suited for filling medications for chronic conditions, as they offer 90-day supplies and automatic refills.

Mail-Order Pharmacies

Mail-Order Pharmacies Community Pharmacies Compounding Pharmacies Immunization

The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices

Pharmacy Times

JULY 21, 2025

The most common concerns include the following 1,3-5 : • Cost and insurance barriers: Affordability remains a major barrier, as patients have difficulty accessing CGMs due to high out-of-pocket costs or limited insurance coverage.

Compounding Pharmacies

Compounding Pharmacies Immunization Insurance Coverage Hospitals

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Pharmacy Times

JULY 12, 2025

3 Her program focuses on an appointment-based model and has a cash-based payment model, although they are able to bill some insurances for the visit. One study conducted in 2016-2017 found that 10% of new prescriptions for contraceptive pills and patches were written by pharmacists during that period.

Independent Pharmacies

Independent Pharmacies Hospitals Compounding Pharmacies Immunization

Ascendis Pharma’s Skytrofa gains FDA approval for growth hormone deficiency

Pharmaceutical Technology

JULY 29, 2025

Give your business an edge with our leading industry insights.

FDA

FDA Packaging Labelling Communication

J&J seeks FDA approval for icotrokinra to treat psoriasis

Pharmaceutical Technology

JULY 22, 2025

Give your business an edge with our leading industry insights.

FDA

FDA Immunization Packaging Communication

Fangzhou and Novo Nordisk link on chronic disease management

Pharmaceutical Technology

JULY 21, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals FDA

Dr Falk Pharma and Allianthera sign agreement for ATB102

Pharmaceutical Technology

JULY 31, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

ViroCell and AvenCell to advance allogeneic CAR-T therapy manufacture

Pharmaceutical Technology

JULY 30, 2025

Give your business an edge with our leading industry insights.

Communication

Communication Packaging Hospitals Insurance

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacy Times

JULY 25, 2025

Additional considerations for selection between oral cephalosporin agents include differences in bioavailability and absorption, specific site of infection and the ability of drug to concentrate at that site, local resistance patterns, insurance coverage, available formulations, and cost to the patient.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Department of Veterans Affairs Immunization Compounding Pharmacies

Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF

Pharmacy Times

JULY 24, 2025

Christopher Ho, PharmD, BCPS, manager of pharmacy telehealth team at Northwell Health, pointed out that many patients with HFpEF are older and lack commercial insurance, making it harder to access branded therapies. Clinical and Practical Barriers Despite the drug’s potential, cost and access are ongoing concerns for finerenone.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Specialty Pharmacies Compounding Pharmacies Hospitals

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Pharmacy Times

JULY 4, 2025

1 For these reasons, the authors conducted this study to evaluate the clinical success and patient outcomes following the mandatory conversion from Humira to a biosimilar because of insurance-related restrictions.

Specialty Pharmacies

Specialty Pharmacies Hospitals Compounding Pharmacies Vaccines

Sanofi concludes Blueprint Medicines acquisition

Pharmaceutical Technology

JULY 21, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals FDA

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Pharmacy Times

JULY 1, 2025

Because] insurance and cost barriers can be difficult for patients, pharmacists can help patients navigate copayment programs and the prior authorization process.” Pharmacists should counsel patients that this agent will slow further progression, but will not reverse existing amyloid deposits.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Specialty Pharmacies Compounding Pharmacies Hospitals

Semaglutide and Tirzepatide Lead the Way in Comprehensive Diabetes and Obesity Management

Pharmacy Times

JULY 23, 2025

Pharmacists are pivotal in patient counseling, therapy selection, and navigating insurance challenges, ensuring comprehensive diabetes management. She also noted the insurance considerations, including involvement with formularies and prior authorization, that come into play when making these decisions.

Insurance

Insurance Compounding Pharmacies FDA Compounding

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

JULY 22, 2025

4 Though the US still stops short of requiring testing outright, this marks a critical turning point—shifting responsibility onto clinicians and paving the way for broader insurance coverage and adoption. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress.

Compounding Pharmacies

Compounding Pharmacies FDA Hospitals Immunization

Pharmacy Policy Updates for June 2025

Pharmacy Times

JUNE 16, 2025

Second, it does not address the core issues of higher prices, such as the use of rebates by insurers. Kennedy Jr, is permitted to develop a new rule that ties American drug prices to those of other nations. First, this may be blocked by a federal judge again. And finally, the most favored nation pricing model is unworkable.”—

Compounding Pharmacies

Compounding Pharmacies Immunization Hospitals Compounding

Re-Vana Therapeutics and Boehringer Ingelheim collaborate for eye therapies

Pharmaceutical Technology

JULY 29, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

GSK’s Blenrep combos approved for multiple myeloma in EU

Pharmaceutical Technology

JULY 25, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals FDA

Janssen’s Darzalex new indication gains EC approval for SMM

Pharmaceutical Technology

JULY 24, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

AstraZeneca announces $50bn US investment plans by 2030

Pharmaceutical Technology

JULY 23, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice

Pharmacy Times

JULY 28, 2025

Treatment selection is influenced by insurance, cost, and patient-specific factors due to the lack of direct RCT comparisons. 7 Based on a lack of head-to-head randomized clinical trials (RCTs), selection of the most appropriate VMAT2 inhibitor is routinely related to insurance approval, affordability, and patient-specific characteristics.

Compounding Pharmacies

Compounding Pharmacies Compounding Insurance Immunization

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

Give your business an edge with our leading industry insights.

Chemotherapy

Chemotherapy Packaging Communication Hospitals

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

Pharmacy Times

JUNE 17, 2025

That means that pharmacists in the twilight of their career have, at some point, filled a prescription, engaged in drug utilization review, filed insurance claims, and counseled per the Omnibus Budget Reconciliation Act of 1990 regulations for many of the products now found in front of the counter.

Compounding Pharmacies

Compounding Pharmacies Drug Utilization Review Immunization Hospitals

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

Pharmacy Times

JUNE 23, 2025

Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurance coverage. But I also think everyone should have a ready-to-use cover on their insurance.

Compounding Pharmacies

Compounding Pharmacies Insurance Immunization Insurance Coverage

Expanding Access: Digital Therapeutics and the Evolving Role of Pharmacists

Pharmacy Times

JULY 3, 2025

Getting this passed would mean broadening coverage within CMS, and then, hopefully, private insurers would follow suit. CMS leads the way when it comes to new therapies and approval, so hopefully, this means broadening access to both private and government-based insurers.

Compounding Pharmacies

Compounding Pharmacies FDA Immunization Packaging

Navigating Rilonacept Therapy: Dose Adjustments, Discontinuation, and Patient Support Strategies

Pharmacy Times

JULY 1, 2025

You also look at sometimes the unfortunate situation of the patient's insurance, for example, no longer covering the medication, whether it's an insurance formulary change or, for example, a patient switches insurances due to a job change. We on our own help to navigate patients through that process as well.

Specialty Pharmacies

Specialty Pharmacies Insurance Compounding Pharmacies Hospitals

Targeting energy expenditure: the next wave of obesity drugs

Pharmaceutical Technology

JULY 31, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

Russell Springs Pharmacy: A Pharmacy That Feels Like Home

Pharmacy Times

JULY 24, 2025

Someone ended up donating a car, and they used the money to buy tires and insurance. The patient was moving away and did not have a car. Loy-Helm jumped into action, mobilizing the staff and patients to raise money to buy her a car. Because the pharmacy is in a rural area, Loy-Helm explained, patients have her phone number.

Independent Pharmacies

Independent Pharmacies Compounding Pharmacies Grocery Stores Immunization

EpiPen patent expiry opens new era for innovation

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News EpiPen patent expiry opens new era for innovation The expiration of Viatris’s EpiPen patent in September 2025 will likely result in increased competition and lower costs in the epinephrine delivery space.

Packaging

Packaging Communication Hospitals Insurance

MAXONA Pharma seeks FDA approval for pain relief MAX-001

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News MAXONA Pharma seeks FDA approval for pain relief MAX-001 MAX-001 provides both rapid onset and extended duration of analgesia. Give your business an edge with our leading industry insights.

FDA

FDA Packaging Compounding Communication

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Pharmaceutical Technology

JULY 18, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Pharmaceutical Companies

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

Pharmaceutical Technology

JULY 16, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

Flu Vaccines Are a Go

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

Trending Sources

Basics on Creating a Lead Generation Network in Pharma

UK enacts law to decentralise manufacture of personalised treatments

GSK’s world-first gonorrhoea vaccine launched in England

Hengrui Pharma and GSK link across key therapeutic areas

How Has Display Advertising Changed in Pharma Marketing?

MetrioPharm gains orphan drug status from EMA for MP1032

FDA gives Arvinas and Pfizer’s vepdegestrant NDA for breast cancer

HS market forecast to reach $7.8bn across 7MM by 2034

Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.

Alfasigma sets stage for Jyseleca in axSpA after Phase III win

The Changing Landscape of Pharmacy Accessibility

The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Ascendis Pharma’s Skytrofa gains FDA approval for growth hormone deficiency

J&J seeks FDA approval for icotrokinra to treat psoriasis

Fangzhou and Novo Nordisk link on chronic disease management

Dr Falk Pharma and Allianthera sign agreement for ATB102

ViroCell and AvenCell to advance allogeneic CAR-T therapy manufacture

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Sanofi concludes Blueprint Medicines acquisition

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Semaglutide and Tirzepatide Lead the Way in Comprehensive Diabetes and Obesity Management

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Policy Updates for June 2025

Re-Vana Therapeutics and Boehringer Ingelheim collaborate for eye therapies

GSK’s Blenrep combos approved for multiple myeloma in EU

Janssen’s Darzalex new indication gains EC approval for SMM

AstraZeneca announces $50bn US investment plans by 2030

Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice

Big pharma braces for revenue headwinds as patent expiries loom

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

Expanding Access: Digital Therapeutics and the Evolving Role of Pharmacists

Navigating Rilonacept Therapy: Dose Adjustments, Discontinuation, and Patient Support Strategies

Targeting energy expenditure: the next wave of obesity drugs

Russell Springs Pharmacy: A Pharmacy That Feels Like Home

EpiPen patent expiry opens new era for innovation

MAXONA Pharma seeks FDA approval for pain relief MAX-001

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

Stay Connected